Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 7—July 2004

Rapid Assessment Tool for Haemophilus influenzae type b Disease in Developing Countries1

Daniel R. Feikin*Comments to Author , Christopher B. Nelson†, James P. Watt*‡, Ezzeddine Mohsni§, Jay D. Wenger†, and Orin S. Levine*‡
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †World Health Organization, Geneva, Switzerland; ‡Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; §World Health Organization, Cairo, Egypt

Main Article

Figure 4

Comparison of incidence rates of Haemophilus influenzae type b (Hib) meningitis per 100,000 children <5 years of age between the rapid assessment tool (gray bars) and prospective, population-based laboratory surveillance (white bars), by region (8–10,12,19–26). (UAE, United Arab Emirates).

Figure 4. Comparison of incidence rates of Haemophilus influenzae type b (Hib) meningitis per 100,000 children <5 years of age between the rapid assessment tool (gray bars) and prospective, population-based laboratory surveillance (white bars), by region (810,12,1926). (UAE, United Arab Emirates).

Main Article

  1. Levine  OS, Schwartz  B, Pierce  N, Kane  M. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young children in developing countries: current status and priority actions. Pediatr Infect Dis J. 1998;17:S9513. DOIPubMedGoogle Scholar
  2. Peltola  H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:30217. DOIPubMedGoogle Scholar
  3. Shann  F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis. 1986;5:24752. DOIPubMedGoogle Scholar
  4. Isaacs  D. Problems in determining the etiology of community-acquired childhood pneumonia. Pediatr Infect Dis J. 1989;8:1438.PubMedGoogle Scholar
  5. Mulholland  K, Levine  O, Nohynek  H, Greenwood  BM. Evaluation of vaccines for the prevention of pneumonia in children in developing countries. Epidemiol Rev. 1999;21:4355.PubMedGoogle Scholar
  6. Levine  OS, Lagos  R, Munoz  A, Villaroel  J, Alvarez  AM, Abrego  P, Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J. 1999;18:10604. DOIPubMedGoogle Scholar
  7. Levine  OS, Schuchat  A, Schwartz  B, Wenger  JD, Elliott  JA. Generic protocol for population-based surveillance for Haemophilus influenzae type b. Document number WHO/VRD/GEN/95.05 1995. Geneva: World Health Organization; 1995.
  8. Cadoz  M, Denis  F, Mar  ID. An epidemiological study of purulent meningitis cases admitted to hospital in Dakar, 1970–1979. Bull World Health Organ. 1981;59:57584.PubMedGoogle Scholar
  9. Campagne  G, Schuchat  A, Djibo  S, Ousseini  A, Cisse  L, Chippaux  JP. Epidemiology of bacterial meningitis in Niamey, Niger, 1981–96. Bull World Health Organ. 1999;77:499508.PubMedGoogle Scholar
  10. Adegbola  RA, Mulholland  EK, Falade  AG, Secka  O, Sarge-Njai  R, Corrah  T, Haemophilus influenzae type b disease in the western region of The Gambia: background surveillance for a vaccine efficacy trial. Ann Trop Paediatr. 1996;16:10311.PubMedGoogle Scholar
  11. Bijlmer  HA, van Alphen  L, Greenwood  BM, Brown  J, Schneider  G, Hughes  A, The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa. J Infect Dis. 1990;161:12105.PubMedGoogle Scholar
  12. Tall  T, Elola  A, Prazuck  T, Traore  A, Nacro  B, Vincent-Ballereau  F. Meningites a Haemophilus influenzae a Bobo-Kioulasso (Burkina Faso). Med Mal Infect. 1992;22:11737. DOIGoogle Scholar
  13. Adams  WG, Deaver  KA, Cochi  SL, Plikaytis  BD, Zell  ER, Broome  CV, Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:2216. DOIPubMedGoogle Scholar
  14. Broome  CV. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J. 1987;6:77982. DOIPubMedGoogle Scholar
  15. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group. Pediatr Infect Dis J. 1999;18:S1722. DOIPubMedGoogle Scholar
  16. Garenne  M, Ronsmans  C, Campbell  H. The magnitude of death from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q. 1992;45:18091.PubMedGoogle Scholar
  17. World Health Organization. Implementation of the global strategy for health for all by the Yyear 2000, second evaluation; and eighth report on the world health situation. Document A45/3 1992. Geneva: The Organization; 1992.
  18. Shaltout  AA, Auger  LT, Awadallah  NB, Hijazi  Z, Johny  M, Hajj  KE, Morbidity and death of bacterial meningitis in Arab children. J Trop Med Hyg. 1989;92:4026.PubMedGoogle Scholar
  19. Zaki  M, Daoud  AS, ElSaleh  Q, West  PW. Childhood bacterial meningitis in Kuwait. J Trop Med Hyg. 1990;93:711.PubMedGoogle Scholar
  20. Uduman  SA, Adeyemi  E, El-Khadir  A, Jose  K, Benedict  S, Bener  A. Haemophilus influenzae type b still remains a leading cause of meningitis among unvaccinated children—a prospective CSF analysis study. J Trop Pediatr. 2000;46:3314. DOIPubMedGoogle Scholar
  21. Novelli  VM, el-Baba  F, Lewis  RG, Bissell  PS. Haemophilus influenzae type b disease in an Arab Gulf state. Pediatr Infect Dis J. 1989;8:8867. DOIPubMedGoogle Scholar
  22. Almuneef  M, Alshaalan  M, Memish  Z, Alalola  S. Bacterial meningitis in Saudi Arabia: the impact of Haemophilus influenzae type b vaccination. J Chemother. 2001;13(Suppl 1):349.PubMedGoogle Scholar
  23. Kojouharova  M, Gatcheva  N, Setchanova  L, Robertson  SE, Wenger  JD. Epidemiology of meningitis due to Haemophilus influenzae type b in children in Bulgaria: a prospective, population-based surveillance study. Bull World Health Organ. 2002;80:6905.PubMedGoogle Scholar
  24. Zielinski  A, Tomaszunas-Blaszczyk  J, Kuklinska  D. Epidemiology of childhood bacterial meningitis in Poland. Incidence of bacterial meningitis with special reference to Haemophilus influenzae type b among children 0-59 months old in the former Kielce and Bydgoszcz districts in Poland in 1998–1999. Eur J Epidemiol. 2001;17:77982. DOIPubMedGoogle Scholar
  25. Bennett  JV, Platonov  AE, Slack  MPE, Mala  P, Burton  AH, Robertson  SE. Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case-fatality. World Health Organization. Document number WHO/V&B/02.18. Available from:
  26. Steinhoff  MC. Invasive Haemophilus influenzae disease in India: a preliminary report of prospective multihospital surveillance. IBIS (Invasive Bacterial Infections Surveillance) Group. Pediatr Infect Dis J. 1998;17:S1725. DOIPubMedGoogle Scholar
  27. Gessner  BD; Hib study group. A randomized, controlled clinical trial of the effect of Haemophilus influenzae type b (Hib) vaccine on pneumonia and meningitis in children living on Lombok Island, Indonesia. In: Program and Abstracts of the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy: September 14-17, 2003; Chicago, IL. Abstract G-2054a. Washington: American Society for Microbiology; 2003.
  28. Russell  FM, Carapetis Jr, Mansoor O, Darcy A, Fakakovi T, Metai A, et al. High incidence of Haemophilus influenzae type b infection in children in Pacific Island countries. Clin Infect Dis. 2003;37:15939. DOIPubMedGoogle Scholar

Main Article

1Some of the content of this manuscript has previously been presented in a document on the Web site of the World Health Organization (

Page created: January 27, 2011
Page updated: January 27, 2011
Page reviewed: January 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.